日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine

预测接受多功能Wilms肿瘤1 (WT1)肽混合物脉冲树突状细胞疫苗化疗免疫疗法转化手术的晚期胰腺癌患者的疗效

Koido, Shigeo; Taguchi, Junichi; Shimabuku, Masamori; Bito, Tuuse; Morimoto, Soyoko; Oji, Yusuke; Oka, Yoshihiro; Ito, Masaki; Shimizu, Yoko; Ito, Zensho; Uchiyama, Kan; Saruta, Masayuki; Sato, Nobuhiro; Ohkusa, Toshifumi; Shimodaira, Shigetaka; Sugiyama, Haruo

Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumor

在表达 Wilms 肿瘤基因 1 的实体瘤患者中,Wilms 肿瘤基因 1 特异性细胞毒性 T 淋巴细胞发生自发性高克隆扩增

Morimoto, Soyoko; Tanaka, Yukie; Nakata, Jun; Fujiki, Fumihiro; Hasegawa, Kana; Nakajima, Hiroko; Nishida, Sumiyuki; Tsuboi, Akihiro; Hosen, Naoki; Kagawa, Naoki; Maruno, Motohiko; Myoui, Akira; Enomoto, Takayuki; Izumoto, Shuichi; Sekimoto, Mitsugu; Hashimoto, Naoya; Yoshimine, Toshiki; Kumanogoh, Atsushi; Oji, Yusuke; Oka, Yoshihiro; Sugiyama, Haruo

Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors

利用免疫蛋白酶体抑制剂增强间皮瘤细胞中 Wilms 肿瘤 1 表位的免疫原性

Masaki Ito,Shigeo Koido,Takeo Iwamoto,Soyoko Morimoto,Fumihiro Fujiki,Haruo Sugiyama,Saki Matsumoto,Clara Effenberger,Kazuma Kiyotani,Kiyotaka Shiba

Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs

建立一种新的NFAT-GFP报告平台,用于HLA II类限制性TCR的功能亲和力成熟

Fumihiro Fujiki, Soyoko Morimoto, Yuya Nishida, Satoe Tanii, Nao Aoyama, Miki Inatome, Kento Inoue, Akiko Katsuhara, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama

An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia

由 WT1 锚定的转基因长双歧杆菌组成的口服 WT1 蛋白疫苗可为患有急性髓系白血病的小鼠提供肠道免疫力

Natsuki Nakagawa, Yoshiko Hashii, Hisako Kayama, Ryu Okumura, Hiroko Nakajima, Hikaru Minagawa, Soyoko Morimoto, Fumihiro Fujiki, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Kiyoshi Takeda, Akihiro Tsuboi, Keiichi Ozono

WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1

针对表达共同靶点 WT1 的罕见癌症的基于 WT1 三肽的癌症疫苗

Oji, Yusuke; Kagawa, Naoki; Arita, Hideyuki; Naka, Norifumi; Hamada, Ken-Ichiro; Outani, Hidetatsu; Shintani, Yasushi; Takeda, Yoshito; Morii, Eiichi; Shimazu, Kenzo; Suzuki, Motoyuki; Nishida, Sumiyuki; Nakata, Jun; Tsuboi, Akihiro; Iwai, Miki; Hayashi, Sae; Imanishi, Rin; Ikejima, Sayaka; Kanegae, Mizuki; Iwamoto, Masahiro; Ikeda, Mayu; Yagi, Kento; Shimokado, Haruka; Nakajima, Hiroko; Hasegawa, Kana; Morimoto, Soyoko; Fujiki, Fumihiro; Nagahara, Akira; Tanemura, Atsushi; Ueda, Yutaka; Mizushima, Tsunekazu; Ohmi, Masato; Ishida, Takayuki; Fujimoto, Manabu; Nonomura, Norio; Kimura, Tadashi; Inohara, Hidenori; Okada, Seiji; Kishima, Haruhiko; Hosen, Naoki; Kumanogoh, Atsushi; Oka, Yoshihiro; Sugiyama, Haruo

Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia

在小鼠白血病模型中,一种新型口服含辅助表位的WT1蛋白疫苗表现出增强的抗肿瘤活性。

Minagawa, Hikaru; Hashii, Yoshiko; Nakajima, Hiroko; Fujiki, Fumihiro; Morimoto, Soyoko; Nakata, Jun; Shirakawa, Toshiro; Katayama, Takane; Tsuboi, Akihiro; Ozono, Keiichi

Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain

使用识别普遍存在的蛋白质 CD98 重链的单克隆抗体选择性靶向多发性骨髓瘤细胞

Kana Hasegawa, Shunya Ikeda, Moto Yaga, Kouki Watanabe, Rika Urakawa, Akie Iehara, Mai Iwai, Seishin Hashiguchi, Soyoko Morimoto, Fumihiro Fujiki, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Satoshi Yoshihara, Masahiro Manabe, Hiroyoshi Ichihara, Atsuko Mugitani, Ya

T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy

细胞内在维生素A代谢及其信号传导是基于记忆性T细胞的癌症免疫疗法的靶点

Fujiki, Fumihiro; Morimoto, Soyoko; Katsuhara, Akiko; Okuda, Akane; Ogawa, Saeka; Ueda, Eriko; Miyazaki, Maki; Isotani, Ayako; Ikawa, Masahito; Nishida, Sumiyuki; Nakajima, Hiroko; Tsuboi, Akihiro; Oka, Yoshihiro; Nakata, Jun; Hosen, Naoki; Kumanogoh, Atsushi; Oji, Yusuke; Sugiyama, Haruo

Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

靶向WT1的HLA I类限制性肽癌症疫苗诱导的细胞和体液免疫反应与晚期卵巢癌的良好临床结局相关

Sumiyuki Nishida,Soyoko Morimoto,Yusuke Oji,Satoshi Morita,Toshiaki Shirakata,Takayuki Enomoto,Akihiro Tsuboi,Yutaka Ueda,Kiyoshi Yoshino,Alzaaqi Shouq,Mizuki Kanegae,Satoshi Ohno,Fumihiro Fujiki,Hiroko Nakajima,Yoshiki Nakae,Jun Nakata,Naoki Hosen,Atsushi Kumanogoh,Yoshihiro Oka,Tadashi Kimura,Haruo Sugiyama